Citizens Maintains Market Outperform on Precigen, Raises Price Target to $9
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
Citizens analyst Jason N. Butler maintains Precigen (NASDAQ:PGEN) with a Market Outperform and raises the price target from $8 to $9.
Citizens analyst Jason N. Butler maintains Precigen (NASDAQ:PGEN) with a Market Outperform and raises the price target from $8 to $9.